APPLICATION
BLA761450
TYPE
BLA
ORIGINAL APPROVAL
2025-11-13
LATEST ACTION
2025-11-13
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
POHERDYPrescription
PERTUZUMAB-DPZB 420MG/14ML(30MG/ML) · INJECTABLE · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.